Litigation Details for In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation (D. Mass. 2014)

In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation (D. Mass. 2014)

Docket		Date Filed	2014-02-25
Court	District Court, D. Massachusetts	Date Terminated	2018-07-18
Cause	15:1 Antitrust Litigation	Assigned To
Jury Demand	Both	Referred To
Parties	SOLODYN (MINOCYCLINE HYDROCHLORIDE) ANTITRUST LITIGATION
Patents	7,541,347; 7,544,373; 7,790,705; 7,919,483; 8,252,776; 8,268,804
Attorneys	Tara Reinhart
Firms	Simpson Thacher & Bartlett LLP
Link to Docket	External link to docket

Details for In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation (D. Mass. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-01-11	931		U.S. Patent No. 7,541,347 (“’347 Patent”), U.S. Patent No. 7,544,373 (“’373 Patent”), U.S. Patent No. …including U.S. Patent No. 5,908,838 (“’838 patent”) and U.S. Patent No. 7,790,705 (“’705 Patent”). Additionally…7,919,483 (“’483 Patent”), U.S. Patent No. 8,268,804 (“’804 Patent”), and U.S. Patent No. 8,252,776 (“…expert, a patent law professor, to opine on a patent litigant’s chances of success in a patent suit), aff…infringement of Medicis’s patents, as well as the timeline for Impax-Medicis patent litigation. Defendants	External link to document
2018-01-24	948		issued an additional patent to Medicis—U.S. Patent No. 7,790,705 (the “’705 patent”), covering “the method… 30. Medicis holds U.S. Patent No. 5,908,838 (the “’838 patent”), a “[m]ethod for the [t]reatment…reexamination of the ’838 patent, and in June 2010, the United States Patent …the ’838 patent was invalid for obviousness. D. 850 at 17. Subject matter cannot be patented if “the …analyses of multiple Solodyn patents; it is not specific to the ’838 patent. See Kibbe 19 Kibbe’s	External link to document